Southend University Hospital NHS Foundation Trust was an NHS foundation trust which ran Southend University Hospital. It merged with two other trusts to form Mid and South Essex NHS Foundation Trust on 1 April 2020.

During the past decade, Southend University Hospital NHS Foundation Trust conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 7 clinical trials were completed, i.e. on average, 30.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southend University Hospital NHS Foundation Trust" #1 sponsor was "Medical Research Council" with 9 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 7 trials sponsored, "Institute of Cancer Research, United Kingdom" with 7 trials sponsored, "Queen Mary University of London" with 5 trials sponsored and "Anglo Celtic Cooperative Oncology Group" with 5 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southend University Hospital NHS Foundation Trust" #1 collaborator was "AstraZeneca" with 4 trials as a collaborator, "Cancer Research UK" with 4 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator, "Mid and South Essex NHS Foundation Trust" with 2 trials as a collaborator and "University of Sheffield" with 2 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "Southend University Hospital NHS Foundation Trust" are "Breast Cancer" (18 trials), "Melanoma (Skin)" (5 trials), "Metastatic Cancer" (5 trials), "Ovarian Cancer" (4 trials) and "Prostate Cancer" (4 trials). Many other conditions were trialed in "Southend University Hospital NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "Southend University Hospital NHS Foundation Trust" are "Drug" (51 trials), "Procedure" (21 trials), "Radiation" (18 trials), "Biological" (15 trials) and "Other" (14 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (15 trials), "adjuvant therapy" (12 trials), "cyclophosphamide" (7 trials), "fluorouracil" (7 trials) and "cisplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Southend University Hospital NHS Foundation Trust" are 50 trials for "All" genders, 23 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Southend University Hospital NHS Foundation Trust". undefined are not yet recruiting, 5 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Southend University Hospital NHS Foundation Trust, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Southend University Hospital NHS Foundation Trust, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".